Technical analysis of Vyome Holdings, Inc. (HIND): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Vyome Holdings, Inc. operates as a healthcare firm currently in its clinical development phase, concentrating on the creation of innovative medicinal treatments designed to address both immuno-inflammatory conditions and infrequent disorders. Founded in 2017, the company extends its market reach throughout the United States and into global territories, headquartered in Princeton, New Jersey.
Price Performance
| 1 month | -15.52% |
| 3 months | -9.68% |
| Year-to-date | -43.02% |
| 1 year | -70.35% |
| 3 years | -99.95% |
52-Week Range
| 52-week High | $9.56 |
| 52-week Low | $1.75 |
| Avg Volume (90d) | 18K |
Technical Indicators
| SMA 50 | $2.16 |
| SMA 200 | $2.57 |
| Beta | 1.42 |
| 30-day Volatility (annualised) | 33.2% |
| Price vs SMA 50 | -9.1% |
| Price vs SMA 200 | -23.7% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $6.05 | |
| 2025-11 | $5.18 | -14.4% |
| 2025-12 | $3.44 | -33.6% |
| 2026-01 | $1.92 | -44.2% |
| 2026-02 | $3.37 | +75.5% |
| 2026-03 | $2.15 | -36.2% |
| 2026-04 | $2.03 | -5.6% |
| 2026-05 | $2.34 | +15.3% |
| 2026-06 | $2.15 | -8.1% |
| 2026-07 | $2.12 | -1.4% |
| 2026-08 | $2.16 | +1.9% |
| 2026-09 | $1.96 | -9.3% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-15 | | $38M |
| 2026-09-15 | $0.01 | $25M |
| 2026-09-15 | | $91M |
| 2026-09-15 | | |
| 2026-09-15 | $0.15 | $1.04B |
| 2026-09-15 | | $344M |
Price
| Price | $1.96 |
| Market Cap | $14M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 2.32 |
| EV / EBITDA | -0.67 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.00 |
| Current Ratio | 4.37 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -18.08 |